Viewing nowCombinationJ-Force 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201400002 · Approved 2014.01.02 · Insurance code 645404240
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension where adequate control is not achieved with amlodipine or valsartan alone. By using both medications in combination, it helps achieve better blood pressure control and reduce the risk of cardiovascular diseases. Consequently, this medication is utilized to enhance therapeutic efficacy and ensure more stable blood pressure management.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters. Therefore, it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used by individuals allergic to the active ingredients or similar medications, women who are pregnant or may become pregnant, and those who are breastfeeding. It is also not safe for individuals with very poor kidney function, serious liver problems, or a history of certain heart conditions or vascular edema. During the use of this medication, special caution is needed if there is dehydration or sodium deficiency, hyperkalemia, or existing kidney issues, as blood pressure could drop too low, requiring close monitoring by a physician. Patients with heart failure, post-myocardial infarction patients, and those with specific heart conditions such as aortic stenosis should also use this medication with caution. Dizziness or fatigue may occur during the treatment, so caution is required while driving or operating machinery. Furthermore, this medication may interact with other drugs, so it is essential to inform the doctor or pharmacist of any other medications being taken. Overdose of this medication can lead to severe hypotension or cardiac issues, so if an overdose is suspected, immediate medical attention is necessary. The safety and efficacy of this medication in children have not been sufficiently established, so it is advisable not to use it in this group. For the elderly, it can be administered at doses similar to those of adult patients, but it should follow the physician’s guidelines based on their condition. Finally, as this medication can affect kidney and liver function, regular check-ups are important to monitor the condition.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, postural dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, fatigue, frequent urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, double vision, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste abnormalities, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, indigestion, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, sensory impairment, Stevens-Johnson syndrome, headache, dizziness, itching, peripheral edema, hypotension, edema, chest pain, pain, cough, nocturnal enuresis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture and should be stored in a sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness.
Dark yellow round film-coated tablets
28 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.